Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Indivior Plc LSE:INDV London Ordinary Share GB00BRS65X63 ORD USD0.10
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -2.40 -1.61% 147.10 146.50 146.70 150.50 146.50 147.50 797,170 16:35:21
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 473.2 -126.5 -14.6 - 1,080

Indivior Share Discussion Threads

Showing 3401 to 3421 of 3750 messages
Chat Pages: Latest  138  137  136  135  134  133  132  131  130  129  128  127  Older
DateSubjectAuthorDiscuss
08/7/2020
09:35
DNL =BIG Drug with potential FDA approval in 2 months = 5+ BAGGER GEM Diurnal Group (DNL) = MCap £38 M / Cash £15 M or enough untill early 2022 / LOTS of BIG milestones on the way = Still the MOST attractive and CHEAPEST pharma stock in UK has potential to run toward 200p very fast especially on approval of Alkindi in USA (expected in September) and Chronocort in Europe (expected in Q1 ) =STRONG BUY AGGRESSIVE a sleeping iant here .GL Market Cap £38 million Cash £15 million Price 30p Alkindi approval in Australia expected this Quarter Alkindi approval in Israel expected this Quarter FDA decision for Alkindi on September 29 EMA Decision for Chronocort expected in early Q1 2021
ih_116147
08/7/2020
09:29
INDV2000 Clinical Trial is now recruiting Potentially huge news for C4XD £16m Mkt Cap they could be due significant milestone on this $294m licence deal hTtps://twitter.com/Stockonomist/status/1280776281303461888?s=20
the stigologist
08/7/2020
08:39
Aggregate of Standard Life Aberdeen plc affiliated Selling a few on behalf of clients Total number of voting rights of issuervii 732,436,173 13.42% still held
la forge
07/7/2020
17:37
[United States] INDIVIOR PLC (INVVY) Delayed Quote. Delayed OTC Bulletin Board - Other OTC - 07/07 00:19:13 pm 10.66 USD -6.98% A SLOW DUMPING BE AHAPPIN
waldron
06/7/2020
20:26
Hi all, My mate Peter @Conkers3 and myself did a Twin Petes Investing Podcast a few days ago and part of our discussion covers INDV. We also chatted about loads of other Stocks and as always a fair bit of general Portfolio Management educational stuff. Anyway, if you use Apple, Audioboom, Overcast or Spotify you can find it under the 'Conkers Corner' Channel (you want TPI Podcast 26) and you can find it on Soundcloud at the link below. I hope you enjoy it and find it useful, Cheers, WD @wheeliedealer hTTps://soundcloud.com/user-479955511/conkers3-wheeliedealer-26-winning-stocks-ytd-ocdo-avct-smt-pog-phe-ao-indv-bvc-cmcx
thewheeliedealer
06/7/2020
09:40
Price (GBX) 92.35 1.48% INDVORD USD0.10 Open / Last close 90.00 / 91.00 High / Low 92.35 / 90.00 Bid / Offer 92.05 / 92.50 Special Condition: - Trading Status: Regular Trading FTSE All-Share
maywillow
04/7/2020
07:07
next strong resistence 103.10p
waldron
03/7/2020
20:13
Indeed! Really struggling on exit strategy here. Surely needs to be something concrete behind this run else we’re in for a steep dump....
jonsols
03/7/2020
16:38
90 to 100p$$$$$$$$$$$$$ WE ARE HERE $$$$$$$$$$$$$$$
waldron
03/7/2020
16:37
Price (GBX) 90.90 10.38% Open / Last close 83.40 / 82.35 High / Low 92.20 / 83.35 Bid / Offer 90.70 / 91.20
waldron
02/7/2020
18:31
Price (GBX) 82.35 +5.24% Open / Last close - / 82.35 High / Low 83.70 / 76.65 Bid / Offer 82.90 / 83.50
waldron
02/7/2020
18:28
INDIVIOR PLC (INVVY) Delayed Quote. Delayed OTC Bulletin Board - Other OTC - 07/02 06:11:56 pm 11.45 USD -4.90%
waldron
02/7/2020
16:09
Seems like he will not be facing the electric chair.
meijiman
02/7/2020
15:43
INDV Https://www.marketscreener.com/INDIVIOR-19344116/ Real-time Estimate CHI-X - 07/02 03:45:43 pm 83 GBX +6.07% INVVY ADR USD SHOULD BE EQUAL 5 TIMES INDV SHARES Https://www.marketscreener.com/INDIVIOR-PLC-19356217/ AS CAN BE SEEN THIS IS NOT THE CASE Delayed Quote. Delayed OTC Bulletin Board - Other OTC - 07/02 03:24:41 pm 11.6 USD -3.65% CURRENTLY THE PUMPED UP share price IS MORE THAN DOUBLE
waldron
02/7/2020
10:21
Stigolist- your scenario is highly plausible!
gregmorg
01/7/2020
22:47
US 'look through' price still over 100% premium to UK price
the stigologist
01/7/2020
22:45
How about Thaxter 'takes one for the team' ? In return INDV treat him as a 'good leaver' and he still gets pension/options etc? I'm inclined to see this positively If they're only talking 1 year prison sounds like he may get suspended sentence or may be open prison ?
the stigologist
01/7/2020
18:48
INDIVIOR PLC (INVVY) Delayed Quote. Delayed OTC Bulletin Board - Other OTC - 07/01 06:29:43 pm 11.52 USD -11.38%
waldron
01/7/2020
17:47
INDIVIOR PLC (INVVY) Delayed Quote. Delayed OTC Bulletin Board - Other OTC - 07/01 00:28:31 pm 11.13 USD -14.38%
waldron
01/7/2020
13:27
Indivior Notes Former CEO's US DoJ Plea In "Personal Capacity" Wed, 1st Jul 2020 10:50 Alliance News (Alliance News) -Â Indivior PLC on Wednesday noted that former chief executive Shaun Thaxter has entered into a plea agreement with the US Department of Justice. He has pleaded guilty to one misdemeanor count under the Responsible Corporate Officer Doctrine. The plea agreement between Thaxter and the DoJ is "in his personal capacity and not on behalf of the group", Indivior stressed. "As the group has previously noted, it continues to pursue its strategy to resolve outstanding investigations and litigations as expeditiously as possible, and as the matter is ongoing it has no further comment," the drug maker said. On Monday, Indivior said Chief Financial & Operations Officer Mark Crossley would replace Thaxter as chief executive with immediate effect. Thaxter, in mutual agreement with the board, stepped down as chief executive and executive director. Indivior is currently locked in a legal battle over Suboxone Film, after it was indicted by a grand jury in a case bought by the US Department of Justice. The DoJ is seeking USD3 billion and has accused Indivior of health care fraud, wire fraud, mail fraud, and conspiracy in connection with its marketing and promotion of Suboxone Film, as well as paediatric safety claims and over-prescription. Indivior shares were up 1.3% at 84.09 pence in London on Wednesday. By Lucy Heming;Â lucyheming@alliancenews.com
maywillow
01/7/2020
13:26
Indivior ex-CEO could face jail time after opioid conviction Indivior ex-CEO could face jail time after opioid conviction Phil TaylorPhil Taylor July 1, 2020 The resignation of Indivior chief executive Shaun Thaxter this week was swiftly followed by a guilty plea – and possible prison sentence – after he pleaded guilty in a US federal court to charges related to an opioid drug. Thaxter resigned from Indivior just before pleading guilty yesterday to one misdemeanour count of mis-representing the safety of Suboxone Film (buprenorphine/naloxone), an opioid-based drug used by recovering addicts to mitigate withdrawal symptoms. He has agreed to pay $600,000 in fines and forfeiture and faces up to one year in prison, according to the US Department of Justice. Sentencing is due to take place on 29 September. Last year, Indivior paid $1.4 billion to settle federal and state allegations that it had mis-sold Suboxone Film, but still faces a criminal case alleging that it engaged in an illicit nationwide scheme to increase prescriptions, due to be heard on 8 September. It continues to deny wrongdoing. Shaun Thaxter In his personal capacity, Thaxter was called to answer specific charges that he caused Indivior employees to misrepresent Suboxone Film’s safety to Massachusetts’ Medicaid programme MassHealth. The DoJ says Thaxter asked Indivior employees to come up with a strategy to win preferred drug status for Suboxone Film over a non-opioid competitor MassHealth was considering for opioid-addiction treatment. That included an internet and telephone service that connected opioid users to doctors known to be high opioid prescribers, it adds. As a result, there was “false and misleading safety information with MassHealth officials about Suboxone Film’s risk of accidental paediatric exposure”, which resulted in MassHealth providing the drug to Medicaid patients with children under the age of six. “By valuing profits over patients, Thaxter’s directions endangered numerous Medicaid beneficiaries and their families, especially young children, with accidental opioid exposure,” commented Elton Malone, an investigator with the Department of Health and Human Services (DHHS). Slough, UK-based Indivior – formerly known as Reckitt Benckiser Pharma – replaced Thaxter as CEO on an interim basis with Mark Crossley, who has served as the company’s chief financial and operations officer for a little over three years. Crossley’s CFO duties will be taken over by Ryan Preblick, currently head of global financial planning and analysis commercial operations at the company. The lawsuits come after a torrid couple of years for Indivior in which it also suffered a major defeat in the US courts over patent protection for Suboxone Film, opening the door to early generic competition for the drug which accounts for the bulk of its sales. In the first quarter of this year, the company’s revenues fell by more than a third to $153 million, having already declined from more than $1 billion in 2018 to $785 million last year. Indivior said in May that it had raised the provision set aside to cover potential product liabilities to $621 million from $438 million. It is trying to compensate with the launch of new products such as long-acting schizophrenia therapy Perseris (risperidone), but sales of that product have been modest so far at just $3 million in the first three months of 2020. It also sells another buprenorphine-based opioid withdrawal product called Sublocade in the US, and recently claimed approval for the drug as Subutex in Sweden, its first European market. The EMA’s human medicines committee recommended approval for Suboxone Film in the EU earlier this year. Don't miss your daily pharmaphorum news.
maywillow
Chat Pages: Latest  138  137  136  135  134  133  132  131  130  129  128  127  Older
ADVFN Advertorial
Your Recent History
LSE
INDV
Indivior
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210512 19:49:09